STING1 and breast neoplasm: Both in vitro and in vivo studies reveal that by triggering pyroptosis and activating the cGAS‐STING pathway, our nanodrugs exhibit potent cytotoxicity and accurate selectivity in eradicating orthotopic breast tumors.